跳至主要内容
临床试验/ACTRN12611000886987
ACTRN12611000886987已完成未知

Effects of metformin plus rosuvastatin on hyperandrogenism in polycystic ovary syndrome patients with hyperlipidemia and impaired glucose tolerance

Ozlem Celik0 个研究点目标入组 40 人开始时间: 2011年8月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • PCOS was defined according to Rotterdam European Society for Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine(ASRM) consensus workshop. All patients had at least two of the following three criteria: chronic anovulation, clinical and/or biochemical hyperandrogenism, and polycystic ovaries on ultrasound (USG).

排除标准

  • The patients who had liver and kidney diseases and using drugs affecting insulin sensitivity and lipid profile and oral contraceptives within the last six months were excluded from the study. Patients with Cushing's syndrome, hyperprolactinemia, diabetes mellitus, thyroid disease, congenital adrenal hyperplasia and androgen-secreting tumors, insufficient LH syndrome and other endocrinopathies were also excluded from the study.

研究者

发起方
Ozlem Celik

相似试验

招募中
4 期
Does Metformin potentiate the effect of Rosuvastatin therapy on biochemical markers in Patients with Polycystic Ovary Syndrome?Polycystic ovary syndrome (PCOS)Reproductive Health and Childbirth - Other reproductive health and childbirth disorders
ACTRN12612000663853American University of Beirut54
尚未招募
4 期
How does administering Metformin (a key drug for diabetes) and Atorvastatin (a key drug for cholesterol reduction) help in mild COVID-19 disease?
CTRI/2021/11/038065All India Institute of Medical Sciences AIIMS Bibinagar Hyderabad
进行中(未招募)
不适用
The effect of metformin co-treatment in hormone-replacement frozen embryo replacement cycles in women with polycystic ovary syndrome. - Metformin in frozen embryo replacement cycles in women with PCOSPolycystic Ovary Syndrome
EUCTR2009-017245-64-GBeeds Teaching Hospitals NHS Trust140
进行中(未招募)
1 期
The effects of rosuvastatin therapy on glucose metabolism in non-diabetic renal transplant recipients with a focus on insulin sensitivity and pancreatic beta islet cell function - Statins, renal transplantation and glucose metabolismew-onset diabetes after transplantationMedDRA version: 8.1 Level: LLT Classification code 10063634 Term: Post transplant diabetes mellitus
EUCTR2005-002777-68-GBCardiff and Vale NHS Trust20
已完成
3 期
Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and DyslipidemiaType 2 DiabetesDyslipidemia
NCT02827903Jeil Pharmaceutical Co., Ltd.237